Medical Design Technology

Radiology

Subscribe to Radiology

New Georgia Advanced Surgery Center Provides Women Many Unique Benefits

June 2, 2010 6:39 pm | by Bio-Medicine.Org | News | Comments

CARTERSVILLE, Ga. ; June 2 /- The Georgia Advanced Surgery Center for Women (GASC) – Georgia 's first fully accredited surgical center for performing all major and minor gynecological surgeries in a true outpatient setting – has officially opened.  The state-of-the-art...

Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology

June 2, 2010 6:39 pm | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY , June 2 /- Amedica Corporation, a spinal and orthopaedic implant and instrument manufacturer focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted United States Patent No. 7,695,521 covering its novel hip implant featuring a...

Questcor to Present at the Jefferies 2010 Global Life Sciences Conference

June 2, 2010 4:40 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif. , June 2 /- Questcor Pharmaceuticals, Inc . (Nasdaq: QCOR ) announced today that it will present at the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010 at The Grand Hyatt Hotel in New York, New York . Don M. Bailey , President and Chief...

Advertisement

CerviLenz plus progesterone could halve preterm birth risk

June 1, 2010 9:42 pm | by Mass Device | News | Comments

Combined with progesterone, the Cervilenz device could help answer the $26 billion-a-year problem of preterm birth in the U.S. By Mary Vanac CerviLenz is a simple, low-tech medical device that prompts a “why didn’t I think of that?” response from many...

MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software

June 1, 2010 4:43 am | by Bio-Medicine.Org | News | Comments

HELSINKI , June 1, 2010 /- MediSapiens, world's first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million ( EUR 0.8 million ) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and Lifeline...

Centene Corporation to Present at Two Upcoming Healthcare Conferences in June

May 28, 2010 11:41 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS , May 28 /- Centene Corporation (NYSE: CNC ) today announced it will present at two upcoming healthcare conferences in the next few weeks. At the Goldman Sachs 31st Annual Global Health Care Conference, to be held June 14-17, 2010 , at the Hyatt Regency Century Plaza in Los...

US HIFU Acquires European Distribution Rights of the Sonablate® 500 Medical Device and Ownership of the Sonatherm® 600 Medical Device

May 28, 2010 6:40 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C. , May 28 /- USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix (Nasdaq: MSON ) HIFU assets...

Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

May 27, 2010 10:42 am | by Bio-Medicine.Org | News | Comments

NEW YORK , May 27 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 http://www.reportlinker.com/p0202881/Global-Renal-Dialysis-Equipment-Pip......

Advertisement

Reportlinker Adds Medical Device Distributors - Europe

May 27, 2010 10:42 am | by Bio-Medicine.Org | News | Comments

NEW YORK , May 27 /- Reportlinker.com announces that a new market research report is available in its catalogue: Medical Device Distributors - Europe http://www.reportlinker.com/p0202116/Medical-Device-Distributors---Europ... This register contains information about...

For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System

May 26, 2010 6:40 am | by Bio-Medicine.Org | News | Comments

PARIS , May 26, 2010 /- InspireMD, Ltd. announced today the next generation MGuard stent, MGuard Prime(R), a net protective Cobalt Chromium stent system. MGuard Prime(R) offers an advanced patented Cobalt Chromium design, superior flexibility and excellent deliverability on top of the...

Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol

May 21, 2010 9:38 am | by Bio-Medicine.Org | News | Comments

BOSTON , May 21 /- Bayer HealthCare Pharmaceuticals, Inc. today announced presentation of data in a poster titled "Results from a multicenter, open-label Phase 3 study to determine the safety and efficacy of gadobutrol, a macrocyclic 1.0 molar GBCA in patients referred for...

Study Data Show INTUNIVâ„¢ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents

May 21, 2010 7:39 am | by Bio-Medicine.Org | News | Comments

NEW ORLEANS , May 21 /- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV™ (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention...

Sorrento Therapeutics Awarded NIH Grant for MRSA Program

May 21, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , May 21 /- Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was...

Bersin & Associates Introduces New Talent Management Framework

May 20, 2010 9:37 am | by Bio-Medicine.Org | News | Comments

OAKLAND, Calif. , May 20 /- Bersin & Associates, the only research and advisory firm focused solely on enterprise learning, talent management, and talent acquisition, today announced the availability of a new report, The Talent Management Framework: A Modern Approach for Developing...

In a World First, Asda Announces 'Not for Profit' Price on All Cancer Treatment Drugs

May 20, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

LEEDS, United Kingdom , May 20 /- Today, in a world first, Asda announces a commitment to sell all privately prescribed cancer treatment drugs on a permanent 'not for profit' basis potentially saving thousands of pounds for sufferers.  Lung disease is the biggest cancer killer of...

Medco to Present at the 2010 Citi Investment Research Global Health Care Conference

May 20, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J. , May 20 /- David B. Snow Jr. , chairman and chief executive officer, Medco Health Solutions, Inc. (NYSE: MHS ), is scheduled to address the 2010 Citi Investment Research Global Health Care Conference in New York on Wednesday, May 26, 2010 . The presentation at the...

Renhuang Pharmaceuticals Exhibits All-Natural Products at the 107th China Import and Export Fair

May 20, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

HARBIN, China , May 20 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the...

Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology

May 20, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , May 20 /- Biocept, Inc. ("Biocept"), an emerging leader in rare cell capture, announced today that the U.S. Patent and Trademark Office has issued a patent for Biocept's cell separation technology using a microfluidic device. U.S. patent #7,695,956 entitled "Device for Cell...

New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season

May 20, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

ST. PAUL, Minn. , May 20 /- Despite concerns from public health officials, influenza antiviral drugs were not hoarded during the recent H1N1 flu season, according to a new analysis presented recently at the Academy of Managed Care Pharmacy's 22nd Annual Meeting in San Diego by Prime...

Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter

May 20, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , May 20 /- Volcano Corporation (Nasdaq: VOLC ) announced today the completion of the first clinical cases using the new Eagle Eye® Platinum digital IVUS catheter. The procedures were performed in seven centers within the United States . Commercial launch of Eagle Eye®...

Nursing and Health launches new master's program

May 19, 2010 10:36 am | by Arizona State University | News | Comments

An academic partnership with the Food and Drug Administration has enabled the launch of a master's degree in regulatory science and health safety, starting fall semester.read more

Stryker Announces Resolution of Two FDA Warning Letters

May 19, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich. , May 19 /- Stryker Corporation (NYSE: SYK ) today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that the actions undertaken to address issues raised in two Warning Letters received in 2007 and 2009 are sufficient.   The Company...

Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment

May 19, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif. , May 19 /- A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010 . The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory...

Boston Scientific Launches Sterling® SL Balloon Catheter in U.S. and Europe

May 19, 2010 5:36 am | by Boston Scientific | News | Comments

Company expands Sterling line of peripheral angioplasty balloon catheters to include long balloons designed for below-the-knee procedures

4-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24, 11 a.m., 9500 Front Street, Lakewood WA 98499

May 18, 2010 12:37 pm | by Bio-Medicine.Org | News | Comments

McCAFFREY ALSO TUES., MAY 25 NOON—RIBBON CUTTING –OPENING NEW CANYON PARK TREATMENT SOLUTIONS, 22026 20 TH AVE. SE, BOTHELL WA 98021, Suite 101 Facilities Confront "The New Heroin", Will Announce 96% Successful Stop of Opiate Abuse within 30 Days Treatment TACOMA, Wash. and...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading